Concepedia

Brendan Frett

BF

Statistics

Publications

33

Citations

1.1K

H-Index

21

Active since

2012

Affiliations

University of Arkansas for Medical Sciences(Current)

University of Arizona

University of Naples Federico II

Institute for Experimental Endocrinology and Oncology

University of Arizona Cancer Center

Brendan Frett is an author at University of Arkansas for Medical Sciences specializing in medicinal chemistry, drug discovery, and pharmacy.

ORCID

Publications per year

2012–2023

33

Publications

33

Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2

Jia Wang, Marat S. Pavlyukov, Hai Yu et al. · Journal of Clinical Investigation · 2017 · 101 citations · Full text

, , +14

Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application

Wei Yan, Naga Rajiv Lakkaniga, Francesca Carlomagno et al. · Journal of Medicinal Chemistry · 2018 · 87 citations · Full text

, , +17

Selective Reduction of Halogenated Nitroarenes with Hydrazine Hydrate in the Presence of Pd/C

Hongyu Li, Fang Li, Brendan Frett · Synlett · 2014 · 69 citations · Full text

, , +5

Efficient Access to 2,3-Diarylimidazo[1,2-<i>a</i>]pyridines via a One-Pot, Ligand-Free, Palladium-Catalyzed Three-Component Reaction under Microwave Irradiation

Yuanxiang Wang, Brendan Frett, Hongyu Li · Organic Letters · 2014 · 63 citations · Full text

, , +13

Structure-based design and synthesis of imidazo[1,2-a]pyridine derivatives as novel and potent Nek2 inhibitors with in vitro and in vivo antitumor activities

Jian-Bei Xi, Yan-Fen Fang, Brendan Frett et al. · European Journal of Medicinal Chemistry · 2016 · 58 citations · Full text

, , +10

1–5 of 33